Diabetes Prevention Program Pilot
Penn State Health (PSH) Diabetes Prevention Program (DPP) Pilot
1 other identifier
interventional
30
1 country
1
Brief Summary
This initiative, which is a partnership between State College area Penn State Health ambulatory care clinics located off campus in the State College area, has two primary goals: 1) improve the health and quality of life of Penn State Health patients with pre-diabetes and 2) decrease associated health care costs due to type 2 diabetes and its complications. The results from the study may serve as a model for additional chronic disease prevention programs to implement in additional Penn State Health clinics in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2020
CompletedFirst Posted
Study publicly available on registry
December 3, 2020
CompletedStudy Start
First participant enrolled
May 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 8, 2023
CompletedSeptember 5, 2023
September 1, 2023
2.2 years
November 24, 2020
September 1, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Weight Loss
Patients will be monitored through out the study for healthy weight loss.
12 months
Subject Retention
Participants will be tracked for retention throughout the study.
12 months
Secondary Outcomes (7)
Blood Pressure
12 months
A1c
12 months
Total Cholesterol
12 months
Pregnancy Status
12 months
Knee Injury and Osteoarthritis Outcome Score (KOOS)
12 months
- +2 more secondary outcomes
Study Arms (4)
Control PSH DPP only
ACTIVE COMPARATORThis group will be enrolled the PSH DPP program. There will be two cohorts for this arm.
Treatment 1 Financial Incentives A
EXPERIMENTALThis group will receive gift cards as financial incentive to participate in the PSH DPP program. There will be two cohorts for this arm.
Treatment 2 Financial Incentives B
EXPERIMENTALThis group will receive gift cards as financial incentive to participate in the PSH DPP program. There will be two cohorts for this arm.
Treatment 3 Motivational Text Messaging
EXPERIMENTALThis group will receive text messages with motivational messages while participating in the PSH DPP program. There will be two cohorts for this arm.
Interventions
Participants will be entered into a lottery to receive a gift card for class attendance.
Participants will be sent motivational messages through out their participation in the PSH DPP program.
All Participants will be enrolled in the DPP program.
Eligibility Criteria
You may qualify if:
- Be at least 18 years old and under age 65 AND
- Body Mass Index ≥25 kg/m2 (≥23 kg/m2 if Asian) AND
- Not be pregnant at time of enrollment AND
- Have no previous diagnosis of type 1 or type 2 diabetes AND
- Have a blood test result in the prediabetes range within the past year, meeting one of these specifications:
- Hemoglobin A1c: 5.7-6.4%, OR
- Fasting plasma glucose : 100-125 mg/dL, OR
- Two-hour plasma glucose (after a 75-gm glucose load): 140-199 mg/dL, OR
- Have a previous clinical diagnosis of gestational diabetes mellitus (GDM), AND
- Not in hypertensive crisis with systolic over 180 and/or diastolic over 120
- Be an established patient at a Penn State Health clinic in State College, PA (i.e. have at least one visit in past 18 months) AND
- Fluent in English AND
- Own and carry an iPhone (running iOS version 10 or higher) or Android (running operating system 7 or higher) smartphone during waking hours
- Internet access
- Tablet or desktop/laptop computer with webcam for classes
- +1 more criteria
You may not qualify if:
- Under 18 years old and over age 65
- Body Mass Index \<25 kg/m2 (\<23 kg/m2 if Asian)
- Pregnant at the time of enrollment
- Previous diagnosis of type 1 or type 2 diabetes
- Have a blood test result within the past year meeting one of these specifications:
- Hemoglobin A1c: not in range of 5.7-6.4%
- Fasting plasma glucose: not in range of 100-125 mg/dL
- Two-hour plasma glucose (after a 75-gm glucose load): not in range of 140-199 mg/dL
- No previous clinical diagnosis of gestational diabetes
- Active hypertensive crisis with systolic over 180 and/or diastolic over 120 (patients in this category would be referred to primary care provider for immediate visit)
- Not be an established patient at a Penn State Health clinic in State College, PA (i.e. have not had at least one visit in the past 18 months)
- Not fluent in English
- Not own and carry an iPhone (running iOS version 10 or higher) or Android (running operating system 7 or higher) smartphone during waking hours.
- Decisional impairment
- Prisoner status
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Penn State Universitylead
- Milton S. Hershey Medical Centercollaborator
Study Sites (1)
Penn State Health Medical Group -- Park Avenue
State College, Pennsylvania, 16803, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will not know what intervention group they will be assigned to (motivational messaging, incentives or control group).
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished Professor of Health Policy and Administration, Director of the Center for Health Care and Policy Research
Study Record Dates
First Submitted
November 24, 2020
First Posted
December 3, 2020
Study Start
May 25, 2021
Primary Completion
August 8, 2023
Study Completion
August 8, 2023
Last Updated
September 5, 2023
Record last verified: 2023-09